Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Granexin Gel in Diabetic Foot Ulcers
NCT02652754Phase 1Completed
- Sponsor
- Xequel Bio
- Start
- Sep 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of zifogaptide in diabetic foot ulcer (DFU), sponsored by Xequel Bio. Primary endpoint: Measurement of aCT1 peptide levels in blood at Day 7. Started Sep 2015; status: completed.
02
Drugs
zifogaptide
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT02652754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02652754.